ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,025.86
0.22%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Clearside Biomedical Inc (CLSD)

  7. Clearside Biomedical Inc (CLSD) Noticias

CLSD Clearside Biomedical Inc

1.35
0.03 (2.27%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Clearside Biomedical Inc CLSD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.03 2.27% 1.35 17:09:02
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.34 1.29 1.35 1.31 1.32
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202406:05GLOBEClearside Biomedical to Report First Quarter 2024 Financial..
16/4/202406:05GLOBEClearside Biomedical Appoints Seasoned Biotechnology..
02/4/202406:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
18/3/202406:05GLOBEClearside Biomedical Appoints Victor Chong, M.D., MBA as..
12/3/202415:05GLOBEClearside Biomedical Announces Fourth Quarter and Full Year..
29/2/202406:05GLOBEClearside Biomedical to Report Fourth Quarter and Full Year..
08/2/202416:05EDGAR2Form 8-K - Current report
08/2/202415:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/2/202407:00GLOBEClearside Biomedical Announces Pricing of $15 Million..
01/2/202415:01EDGAR2Form 8-K - Current report
19/1/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202414:04EDGAR2Form 144 - Report of proposed sale of securities
28/12/202315:10EDGAR2Form 8-K - Current report
14/12/202306:05GLOBEClearside Biomedical Reports Significant Progress in ODYSSEY..
13/11/202315:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202315:10EDGAR2Form 8-K - Current report
13/11/202315:05GLOBEClearside Biomedical Announces Third Quarter 2023 Financial..
08/11/202306:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
07/11/202315:20GLOBEClearside Biomedical’s Versatile Suprachoroidal Injection..
03/11/202311:01EDGAR2Form 8-K - Current report
03/11/202311:00GLOBEBioCryst and Clearside Biomedical Enter Partnership to..
02/11/202306:05GLOBEClearside Biomedical Announces Presentations at the American..
01/11/202306:05GLOBEClearside Biomedical Completes Recruitment in ODYSSEY Phase..
31/10/202306:05GLOBEClearside Biomedical to Report Third Quarter 2023 Financial..
16/10/202306:05GLOBEClearside Biomedical Positive OASIS and Extension Study Data..
04/10/202308:00GLOBEClearside Biomedical Announces Advancement of XIPERE® in..
03/10/202315:35GLOBEClearside Biomedical to Participate in a Panel Discussion at..
29/9/202315:46EDGAR2Form 8-K - Current report
25/9/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202315:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202306:05GLOBEClearside Biomedical to Participate in Panel Discussion at..
13/9/202317:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202315:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:11EDGAR2Form 8-K - Current report
14/8/202315:05GLOBEClearside Biomedical Announces Second Quarter 2023 Financial..
02/8/202315:30GLOBEClearside Biomedical to Participate in Upcoming Investor..
01/8/202306:05GLOBEClearside Biomedical to Report Second Quarter 2023 Financial..
31/7/202306:05GLOBEClearside Biomedical Highlights Excellent Safety Profile of..
20/7/202306:05GLOBEClearside Biomedical’s Suprachoroidal Injection Platform to..
17/7/202306:05GLOBEClearside Biomedical Announces Enrollment of Multiple..
11/7/202315:05GLOBEClearside Biomedical CEO George Lasezkay to Present at the..
10/7/202306:05GLOBEClearside Biomedical Asia-Pacific Partner Arctic Vision..
01/6/202306:05GLOBEClearside Biomedical Opens Enrollment in ODYSSEY Phase 2b..
11/5/202306:05GLOBEClearside Biomedical Announces First Quarter 2023 Financial..
09/5/202315:30GLOBEClearside Biomedical to Participate in a Fireside Chat at..

Su Consulta Reciente

NASDAQ
CLSD
Clearside Biomedical
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados